These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1145 related articles for article (PubMed ID: 10661346)
1. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346 [TBL] [Abstract][Full Text] [Related]
2. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Ryu JK; Winter K; Michalski JM; Purdy JA; Markoe AM; Earle JD; Perez CA; Roach M; Sandler HM; Pollack A; Cox JD Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1036-46. PubMed ID: 12419429 [TBL] [Abstract][Full Text] [Related]
3. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. Michalski JM; Winter K; Purdy JA; Wilder RB; Perez CA; Roach M; Parliament MB; Pollack A; Markoe AM; Harms W; Sandler HM; Cox JD Int J Radiat Oncol Biol Phys; 2003 May; 56(1):192-8. PubMed ID: 12694838 [TBL] [Abstract][Full Text] [Related]
4. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549 [TBL] [Abstract][Full Text] [Related]
5. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Valicenti RK; Winter K; Cox JD; Sandler HM; Bosch W; Vijayakumar S; Michalski J; Purdy J Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):614-20. PubMed ID: 14529764 [TBL] [Abstract][Full Text] [Related]
6. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428 [TBL] [Abstract][Full Text] [Related]
7. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. Michalski JM; Winter K; Purdy JA; Wilder R; Perez CA; Roach M; Parliament M; Pollack A; Markoe A; Harms WB; Sandler H; Cox JD Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):75-80. PubMed ID: 11917289 [TBL] [Abstract][Full Text] [Related]
8. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Dearnaley DP; Hall E; Lawrence D; Huddart RA; Eeles R; Nutting CM; Gadd J; Warrington A; Bidmead M; Horwich A Br J Cancer; 2005 Feb; 92(3):488-98. PubMed ID: 15685244 [TBL] [Abstract][Full Text] [Related]
9. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959 [TBL] [Abstract][Full Text] [Related]
10. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582 [TBL] [Abstract][Full Text] [Related]
11. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Michalski JM; Bae K; Roach M; Markoe AM; Sandler HM; Ryu J; Parliament MB; Straube W; Valicenti RK; Cox JD Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):14-22. PubMed ID: 19577865 [TBL] [Abstract][Full Text] [Related]
12. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Michalski JM; Yan Y; Watkins-Bruner D; Bosch WR; Winter K; Galvin JM; Bahary JP; Morton GC; Parliament MB; Sandler HM Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):932-8. PubMed ID: 24113055 [TBL] [Abstract][Full Text] [Related]
13. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950 [TBL] [Abstract][Full Text] [Related]
15. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785 [TBL] [Abstract][Full Text] [Related]
16. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881 [TBL] [Abstract][Full Text] [Related]
17. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Pollack A; Zagars GK; Starkschall G; Childress CH; Kopplin S; Boyer AL; Rosen II Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):555-64. PubMed ID: 8621278 [TBL] [Abstract][Full Text] [Related]
18. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume? Kupelian PA; Reddy CA; Carlson TP; Willoughby TR Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204 [TBL] [Abstract][Full Text] [Related]
19. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311 [TBL] [Abstract][Full Text] [Related]
20. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]